Delving into the Latest Updates on Amniotic cell therapy (NuCel) with Synapse

Overview

Basic Info

Drug Type

Cell therapy

Synonyms

Amniotic cell therapy(NuCel), Human amniotic allograft

Target-

Action-

Mechanism

Cell replacements

Therapeutic Areas

Skin and Musculoskeletal Diseases

Active Indication-

Inactive Indication

Intervertebral Disc Degeneration

Originator Organization

Nucel Wireless, Inc.

Active Organization-

Inactive Organization

OhioHealth Corp.

License Organization-

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

Login to view timeline

A double-blind, randomized controlled trial designed to evaluate the symptomatic modulating efficacy of amniotic suspension allograft (ASA) in comparison to platelet-rich plasma (PRP), hyaluronic acid (HA) and normal saline (NS) in the injection treatment of knee osteoarthritis. The hypothesis is that ASA would provide the greatest functional improvement.

Start Date01 Jan 2021

Sponsor / Collaborator-

NCT03063099

/ CompletedNot Applicable

A Pilot Study of ReNu™ Hip Injection: Monitoring the Response of Hip Function and Pain in Patient With Osteoarthritis

A pilot study to evaluate changes in hip function and pain in patients with osteoarthritis receiving the ReNu™ Hip Injection.

Start Date08 Feb 2017

Sponsor / Collaborator

NuTech Medical, Inc.

[+1]

NCT02314416

/ WithdrawnPhase 4IIT

Stem Cells In Wound Healing With Collagen Matrix as a Carrier

The purpose of the study is to use a collagen matrix embedded with amniotic stem cells to speed up the maturation and integration of the collagen matrix in the wound bed and shorten total time needed for wound healing.

Start Date01 May 2015

Sponsor / Collaborator

Augusta University Research Institute

[+1]

100 Clinical Results associated with Amniotic cell therapy (NuCel)

Login to view more data

100 Translational Medicine associated with Amniotic cell therapy (NuCel)

Login to view more data

100 Patents (Medical) associated with Amniotic cell therapy (NuCel)

Login to view more data

100 Deals associated with Amniotic cell therapy (NuCel)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Intervertebral Disc Degeneration	Phase 2	United States	OhioHealth Corp.	13 Dec 2013

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


NCT02070484 (CTgov)	Not Applicable	Intervertebral Disc Degeneration \| Spinal Stenosis \| Spondylolisthesis \| Intervertebral Disc Displacement	6	NuCel (NuCel)	(jiixtguxad) = qiizjqwkqb zmwqtcwpsw (onoptodvtn, zuewbseyze - vwlsghlnac) View more	-	27 Aug 2018
				Demineralized Bone Matrix (Demineralized Bone Matrix (DBM))	(jiixtguxad) = mvrfxiktju zmwqtcwpsw (onoptodvtn, qvvgtphwsp - lgnnluzkad) View more